Abstract | BACKGROUND/AIM: PATIENTS AND METHODS: RESULTS: The 5-year overall survival rates were 27.8% for 0-20 harvested LNs, 35.7% for 21-30 harvested LNs, 79.4% for 31-40 harvested LNs, and 85.2% for ≥41 harvested LNs. Thirty harvested LNs was regarded as the optimal critical point of classification, considering the 5-year OS rate. The number of harvested LNs was selected as a significant prognostic factor in both univariate and multivariate analyses. The respective 3- and 5-year OS rates were 50.3% and 36.7% for <30 harvested LNs and 82.4% and 82.4% for ≥30 harvested LNs (p=0.003). CONCLUSION:
|
Authors | Toru Aoyama, Yosuke Atsumi, Shinnosuke Kawahara, Hiroshi Tamagawa, Ayako Tamagawa, Yukio Maezawa, Kazuki Kano, Masaaki Murakawa, Keisuke Kazama, Masakatsu Numata, Takashi Oshima, Norio Yukawa, Munetaka Masuda, Yasushi Rino |
Journal | In vivo (Athens, Greece)
(In Vivo)
2020 Jul-Aug
Vol. 34
Issue 4
Pg. 2021-2027
ISSN: 1791-7549 [Electronic] Greece |
PMID | 32606176
(Publication Type: Journal Article)
|
Copyright | Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. |
Topics |
- Esophageal Neoplasms
(pathology, surgery)
- Esophagectomy
- Humans
- Lymph Node Excision
- Lymph Nodes
(pathology, surgery)
- Lymphatic Metastasis
- Neoplasm Staging
- Prognosis
- Retrospective Studies
- Survival Rate
|